Clinicopathological characteristics and outcomes of ROS1‐rearranged patients with lung adenocarcinoma without EGFR, KRAS mutations and ALK …
S Wu, J Wang, L Zhou, D Su, Y Liu, X Liang… - Thoracic …, 2015 - Wiley Online Library
Background c‐ros oncogene 1 (ROS1) rearrangement presents one of the newest molecular
targets in non‐small cell lung cancer (NSCLC). ROS1 rearrangement is predominantly …
targets in non‐small cell lung cancer (NSCLC). ROS1 rearrangement is predominantly …
Clinicopathological characteristics and outcomes of ROS1-rearranged patients with lung adenocarcinoma without EGFR, KRAS mutations and ALK rearrangements.
S Wu, J Wang, L Zhou, D Su, Y Liu, X Liang… - Thoracic …, 2015 - search.ebscohost.com
Background c-ros oncogene 1 (ROS1) rearrangement presents one of the newest molecular
targets in non-small cell lung cancer (NSCLC). ROS1 rearrangement is predominantly found …
targets in non-small cell lung cancer (NSCLC). ROS1 rearrangement is predominantly found …
[PDF][PDF] Clinicopathological characteristics and outcomes of ROS1-rearranged patients with lung adenocarcinoma without EGFR, KRAS mutations and ALK …
S Wu, J Wang, L Zhou, D Su, Y Liu, X Liang, S Zhang… - cancer - cyberleninka.org
Abstract Background: c-ros oncogene 1 (ROS1) rearrangement presents one of the newest
molecular targets in non-small cell lung cancer (NSCLC). ROS1 rearrangement is …
molecular targets in non-small cell lung cancer (NSCLC). ROS1 rearrangement is …
[HTML][HTML] Clinicopathological characteristics and outcomes of ROS1-rearranged patients with lung adenocarcinoma without EGFR, KRAS mutations and ALK …
S Wu, J Wang, L Zhou, D Su, Y Liu, X Liang… - Thoracic …, 2015 - ncbi.nlm.nih.gov
Background c-ros oncogene 1 (ROS1) rearrangement presents one of the newest molecular
targets in non-small cell lung cancer (NSCLC). ROS1 rearrangement is predominantly found …
targets in non-small cell lung cancer (NSCLC). ROS1 rearrangement is predominantly found …
ROS1 in lung adenocarcinoma
S Wu, J Wang, L Zhou, D Su, Y Liu, X Liang… - Thoracic …, 2015 - search.proquest.com
Background c‐ros oncogene 1 (ROS1) rearrangement presents one of the newest molecular
targets in non‐small cell lung cancer (NSCLC). ROS1 rearrangement is predominantly …
targets in non‐small cell lung cancer (NSCLC). ROS1 rearrangement is predominantly …
[PDF][PDF] Clinicopathological characteristics and outcomes of ROS1-rearranged patients with lung adenocarcinoma without EGFR, KRAS mutations and ALK …
S Wu, J Wang, L Zhou, D Su, Y Liu, X Liang, S Zhang… - cancer - scienceopen.com
Abstract Background: c-ros oncogene 1 (ROS1) rearrangement presents one of the newest
molecular targets in non-small cell lung cancer (NSCLC). ROS1 rearrangement is …
molecular targets in non-small cell lung cancer (NSCLC). ROS1 rearrangement is …
Clinicopathological characteristics and outcomes of ROS1-rearranged patients with lung adenocarcinoma without EGFR, KRAS mutations and ALK rearrangements
S Wu, J Wang, L Zhou, D Su, Y Liu… - Thoracic …, 2015 - pubmed.ncbi.nlm.nih.gov
Background c-ros oncogene 1 (ROS1) rearrangement presents one of the newest molecular
targets in non-small cell lung cancer (NSCLC). ROS1 rearrangement is predominantly found …
targets in non-small cell lung cancer (NSCLC). ROS1 rearrangement is predominantly found …
[PDF][PDF] Clinicopathological characteristics and outcomes of ROS1-rearranged patients with lung adenocarcinoma without EGFR, KRAS mutations and ALK …
S Wu, J Wang, L Zhou, D Su, Y Liu, X Liang, S Zhang… - cancer - Citeseer
Abstract Background: c-ros oncogene 1 (ROS1) rearrangement presents one of the newest
molecular targets in non-small cell lung cancer (NSCLC). ROS1 rearrangement is …
molecular targets in non-small cell lung cancer (NSCLC). ROS1 rearrangement is …
Clinicopathological characteristics and outcomes of ROS1-rearranged patients with lung adenocarcinoma without EGFR, KRAS mutations and ALK rearrangements.
S Wu, J Wang, L Zhou, D Su, Y Liu, X Liang… - Thoracic …, 2015 - europepmc.org
Background c-ros oncogene 1 (ROS1) rearrangement presents one of the newest molecular
targets in non-small cell lung cancer (NSCLC). ROS1 rearrangement is predominantly found …
targets in non-small cell lung cancer (NSCLC). ROS1 rearrangement is predominantly found …